This pilot study evaluated the effects of coadministration of metformin with clomiphene citrate (CC) and human menopausal gonadotrophin (HMG) in women with CC-resistant polycystic ovary syndrome (PCOS). Sixty women with PCOS were randomly assigned to receive 3 months' treatment with metformin or placebo together with CC and HMG. Transvaginal ultrasound was used to monitor follicular development and ovulation was induced by human chorionic gonadotrophin (HCG). The number of dominant follicles, the oestradiol level on the day HCG was given and the amount of HMG required were significantly lower in the metformin group than in the placebo group, whereas the mono-ovulatory rate and pregnancy rate in the third cycle were significantly higher. The cumulative pregnancy rate in the metformin group (43.3%) was higher than in the placebo group (20.0%), but this difference did not reach statistical significance. In conclusion, coadministration of metformin with CC and HMG reduced the amount of HMG required and increased the mono-ovulatory rate and pregnancy rate.
PolsonDWKiddyDSMasonHD: Induction of ovulation with clomiphene citrate in women with polycystic ovary syndrome: The difference between responders and nonresponders. Fertil Steril1989; 51: 30–34.
2.
BayramNvan WelyMKaaijkEM: Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: Randomised controlled trial. BMJ2004; 328: 192.
3.
MurakawaHHasegawaIKurabayashiT: Polycystic ovary syndrome. Insulin resistance and ovulatory responses to clomiphene citrate. J Reprod Med1999; 44: 23–27.
4.
GeorgeSSGeorgeKIrwinC: Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: A randomized, controlled trial. Hum Reprod2003; 18: 299–304.
5.
HarborneLFlemingRLyallH: Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet2003; 361: 1894–1901.
6.
KocakMCaliskanESimsirC: Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril2002; 77: 101–106.
7.
KashyapSWellsGARosenwaksZ: Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome. Hum Reprod2004; 19: 2474–2483.
8.
VandermolenDTRattsVSEvansWS: Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril2001; 75: 310–315.
9.
YaraliHYildizBODemirolA: Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: A prospective randomized trial. Hum Reprod2002; 17: 289–294.
10.
De LeoVla MarcaADittoA: Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril1999; 72: 282–285.
11.
NestlerJEJakubowiczDJEvansWS: Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med1998; 338: 1876–1880.
12.
NgEHWatNMHoPC: Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: A randomized, double-blinded placebo-controlled trial. Hum Reprod2001; 16: 1625–1631.
13.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod2004; 19: 41–47.
14.
RouziAAArdawiMS: A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril2006; 85: 428–435.
15.
LegroRSFinegoodDDunaifA: A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab1998; 83: 2694–2698.
16.
KhorramOHelliwellJPKatzS: Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome. Fertil Steril2006; 85: 1448–1451.
17.
PalombaSOrioFJrFalboA: Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab2005; 90: 4068–4074.
18.
PalombaSOrioFZulloF: Ovulation induction in women with polycystic ovary syndrome. Fertil Steril2006; 86 (suppl 1): S26–S27.
19.
HughesECollinsJVandekerckhoveP: Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. Cochrane Database Syst Rev2000; 2: CD000087.
20.
KobayashiTOdaTYoshimuraY: Androstenedione and progesterone concentrations in preovulatory follicular fluid correlate with successful fertilization and cleavage of human oocytes in vitro. Fertil Steril1991; 56: 301–305.
21.
HomburgRHowlesCM: Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: Rationale, results, reflections and refinements. Hum Reprod Update1999; 5: 493–499.
22.
CostelloMFEdenJA: A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril2003; 79: 1–13.
